BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12605543)

  • 1. Privacy issues in personalized medicine.
    Vaszar LT; Cho MK; Raffin TA
    Pharmacogenomics; 2003 Mar; 4(2):107-12. PubMed ID: 12605543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics--legal, ethical and regulatory considerations.
    March R; Cheeseman K; Doherty M
    Pharmacogenomics; 2001 Nov; 2(4):317-27. PubMed ID: 11722282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging ethical issues in pharmacogenomics: from research to clinical practice.
    Freund CL; Wilfond BS
    Am J Pharmacogenomics; 2002; 2(4):273-81. PubMed ID: 12421098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating personalized genomic medicine into routine clinical care: addressing the social and policy issues of pharmacogenomic testing.
    Dressler LG
    N C Med J; 2013; 74(6):509-13. PubMed ID: 24316779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public good, personal privacy: a citizens' deliberation about using medical information for pharmacoepidemiological research.
    Parkin L; Paul C
    J Epidemiol Community Health; 2011 Feb; 65(2):150-6. PubMed ID: 19948532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4th Annual Pharmacogenomics and Medicine Lectures.
    Oestreicher P
    Pharmacogenomics; 2001 Aug; 2(3):291-6. PubMed ID: 11939134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical, social and legal implications of pharmacogenomics: a critical review.
    Moldrup C
    Community Genet; 2001; 4(4):204-14. PubMed ID: 12751484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Society and ethics - the genetics of disease.
    Thomas SM
    Curr Opin Genet Dev; 2004 Jun; 14(3):287-91. PubMed ID: 15172672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Finding a liability-free space in which personalized medicine can bloom.
    Evans BJ
    Clin Pharmacol Ther; 2007 Oct; 82(4):461-5. PubMed ID: 17713468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of Australian adults about protecting the privacy of their health information in statistical databases.
    King T; Brankovic L; Gillard P
    Int J Med Inform; 2012 Apr; 81(4):279-89. PubMed ID: 22306206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and ethical considerations: why care?
    Marx-Stölting L
    Pharmacogenomics J; 2007 Oct; 7(5):293-6. PubMed ID: 17033614
    [No Abstract]   [Full Text] [Related]  

  • 13. Knowledge and skills needs for health professions about pharmacogenomics testing field.
    Di Francia R; Valente D; Catapano O; Rupolo M; Tirelli U; Berretta M
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):781-8. PubMed ID: 22913211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical, social and legal implications of genetic testing in liver disease.
    van Leeuwen DJ; Bernat JL
    Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stakeholder views on pharmacogenomic testing.
    Patel HN; Ursan ID; Zueger PM; Cavallari LH; Pickard AS
    Pharmacotherapy; 2014 Feb; 34(2):151-65. PubMed ID: 24167008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics and the challenge to privacy.
    Vaszar LT; Rosen GD; Raffin TA
    Pharmacogenomics J; 2002; 2(3):144-7. PubMed ID: 12082584
    [No Abstract]   [Full Text] [Related]  

  • 17. Family consent and the pursuit of better medicines through genetic research.
    Renegar G; Rieser P; Manasco P
    J Contin Educ Health Prof; 2001; 21(4):265-70. PubMed ID: 11803771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.
    Morley KI; Hall WD
    J Mol Med (Berl); 2004 Jan; 82(1):21-30. PubMed ID: 14598045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics and policy perspectives on personalized medicine in the post-genomic era.
    Landon MR
    J Biolaw Bus; 2005; 8(3):28-36. PubMed ID: 16459425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Privacy and confidentiality of genetic information: what rules for the new science?
    Anderlik MR; Rothstein MA
    Annu Rev Genomics Hum Genet; 2001; 2():401-33. PubMed ID: 11701656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.